Application-based coaching for recurrent urinary tract infections in adult women: design of a mixed-methods multicenter randomized controlled trial and process evaluation in the Netherlands
Abstract
Recurrent urinary tract infection (rUTI) healthcare has proven to be a challenge due to different limitations. Digital coaching could provide a solution for these challenges. Earlier, we have developed a digital coach for women with rUTI and pilot-tested this positively. We now aim to assess the clinical effectiveness of this app-based coaching tool and to support its optimal implementation through a comprehensive process evaluation. This article describes the design of the study.
A mixed-methods study will be conducted, consisting of a randomized controlled superiority trial in parallel with an extensive process evaluation. Adult women with rUTI will be randomized to receive care as usual or care as usual with additional mobile coaching, offering interactive education, symptom tracking, lifestyle advice, and self-care strategies. The primary outcome of the RCT is UTI frequency during the 12-month follow-up time. Secondary outcomes include antibiotics usage, patient-reported quality of life, healthcare consumption, and cost-effectiveness. The process evaluation will combine surveys, interviews with patients, focus groups with healthcare professionals and log data to assess acceptability and usability of app-based coaching and to explore barriers and facilitators for implementation of this eHealth tool.
This pragmatic study envisions exploring the additional value of digital coaching to care as usual for women suffering from rUTI through a mixed-methods design in a real-world…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.